IRCT20200217046520N1尚未招募2 期
Cardioprotective Effect of Metformin on the level of micro RNAs, mir-222, mir-195, mir-21a, in type 1 diabetes patients
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 years 至 45 years（—）
- 性别
- All
入选标准
- •age 19 to 45 years
- •insulin-treated
- •for the past three months the patient's blood sugar has been controlled
- •HbA1c ranged from 6/5 to 7/5
- •lack of cardiovascular disease
- •it's been 5 years since diabetes
- •informed consent
排除标准
- •pregnancy or pregnancy intent in the near future
- •Kidney failure (creatinine equal to or greater than 1/3)
- •history of cardiovascular disease
- •history of intraocular injection
- •Glycated haemoglobin greater than 7/5
研究者
相似试验
已完成
不适用
Addition of metformin to growth hormone for short children born small for gestational ageISRCTN19548431Hospital Sant Joan de Deu (Spain)64
招募中
3 期
Evaluation of the Protective Effect of Metformin against the Tamoxifen Induced Changes on Endometrium and OvariesIRCT20140820018866N9Tehran University of Medical Sciences100
进行中（未招募）
1 期
Effects of metformin treatment on myocardial efficiency in patients with heart failureEUCTR2015-002767-42-DKAarhus University Hospital36
已完成
2 期
Evaluation of the effect of metformin in STEMI patients treated with thrombolytic therapyIRCT20111206008307N34Tabriz University of Medical Sciences80
进行中（未招募）
1 期
The MET REMODEL StudyMedDRA version: 17.0 Level: PT Classification code 10022489 Term: Insulin resistance System Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 17.0 Level: LLT Classification code 10051615 Term: Atherosclerotic cardiovascular disease System Organ Class: 100000004866MedDRA version: 17.0 Level: LLT Classification code 10025164 Term: LVH System Organ Class: 100000004849Cardiovascular diseaseEUCTR2014-003189-26-GBniversity of Dundee/NHS Tayside68